...
首页> 外文期刊>Pharmacognosy Research >Evaluation of antitumor activity and antioxidant status of Alternanthera brasiliana against Ehrlich ascites carcinoma in Swiss albino mice
【24h】

Evaluation of antitumor activity and antioxidant status of Alternanthera brasiliana against Ehrlich ascites carcinoma in Swiss albino mice

机译:巴西白桦对瑞士白化病小鼠艾氏腹水癌的抗肿瘤活性和抗氧化状态的评估

获取原文
           

摘要

Objective:The main objective of the present study was to explore the antitumor activity of the ethyl acetate extract of the Alternanthera brasiliana (EAAB) and its antioxidant status against Ehrlich ascites carcinoma (EAC) in Swiss albino mice.Materials and Methods:Based on the preliminary in vitro cytotoxicity studies, EAAB was selected for anti-tumor and antioxidant effects. Anticancer activity of EAAB was evaluated against EAC in Swiss albino mice at the doses of 200 and 400 mg/kg. EAAB was administered for 14 consecutive days after induction of cancer. After 24 h of the last dose and 18 h of fasting, half of the mice were sacrificed and rest were kept alive for assessing any increase in life span. The antitumor effect of EAAB was assessed by evaluating tumor volume, viable and nonviable tumor cell count, tumor weight, hematological and biochemical parameters of EAC bearing host. Furthermore, the antioxidant and histopathological parameters were evaluated.Results:EAAB treatment has shown significant decrease in tumor volume, viable cell count, tumor weight and elevated the life span of EAC tumor bearing mice in a dose dependent manner. In hematological profile count of RBC, hemoglobin, and WBC were found reverted to normal. EAAB also significantly decreased the levels of lipid peroxidation and significantly increased the levels of GSH, SOD and Catalase.Conclusion:From the above results it may be concluded that EAAB has potent dose dependent antitumor activity and is comparable to that of 5-flourouracil.
机译:目的:本研究的主要目的是探讨巴西白粉病乙酸乙酯提取物(EAAB)的抗肿瘤活性及其对瑞士白化病小鼠艾氏腹水癌(EAC)的抗氧化作用。材料与方法:基于在初步的体外细胞毒性研究中,选择EAAB用于抗肿瘤和抗氧化作用。在瑞士白化病小鼠中以200和400 mg / kg的剂量评估EAAB的抗癌活性。诱发癌症后连续14天给予EAAB。最后一剂24小时和禁食18小时后,处死一半小鼠,保持存活以评估寿命的延长。通过评估肿瘤体积,存活和不存活的肿瘤细胞计数,肿瘤重量,携带EAC的宿主的血液学和生化参数来评估EAAB的抗肿瘤作用。结果:EAAB治疗以剂量依赖性方式显着降低了EAC荷瘤小鼠的肿瘤体积,活细胞计数,肿瘤重量并延长了其寿命。在血液学方面,发现红细胞,血红蛋白和白细胞恢复正常。 EAAB还可以显着降低脂质过氧化的水平,并显着提高GSH,SOD和过氧化氢酶的水平。结论:从以上结果可以得出结论,EAAB具有强效的剂量依赖性抗肿瘤活性,可与5-氟尿嘧啶媲美。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号